High materiality7/10
MapLight Therapeutics price target raised to $43 from $35 at Canaccord
Why it may matterVerify against the original reporting
upside_potential
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord raises MPLT target to $43 from $35.23; current price $35.23; upside ≈ 22%.
- Canaccord raises MPLT target to $43; price $35.23; upside ~22%
Key facts
- 01
Target: $43
- 02
Posted price: $35.23
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Sumant Kulkarni
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.